ReviewDrugs2018

Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Nicki Niemann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.